Red Wine Nutrient Resveratrol to be Investigated in a 4 Year Human Clinical Study in Denmark
Red Wine Nutrient Resveratrol to be Investigated in a 4 Year Human Clinical Study in Denmark
Jan 31, 2011
, by
/PRNewswire/ -- The Danish Council for Strategic Research has granted $3.4 million for a four year study to investigate resveratrol on the management of metabolic syndrome, osteoporosis and chronic inflammation. This landmark study is to demonstratively prove that supplemental intake of resveratrol can neutralize the detrimental effects of excess body weight; specifically obesity. The effects to be measured include low-grade inflammation that is often associated with type 2 diabetes, non-alcoholic fatty liver disease, and osteoporosis.
Comments